Mild Traumatic Brain Injury Clinical Trial
— TRUSTOfficial title:
Transcranial Ultrasonography for the Management of Patients With Mild Traumatic Brain Injury
NCT number | NCT03989999 |
Other study ID # | 38RC19.106 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | February 1, 2020 |
Est. completion date | July 2026 |
The investigators hypothesize that patients with mild TBI and normal TCD can be safely discharged home immediately after the ED. The targeted population is the category of patients eligible for early discharge: 1) patients with mild lesions on the initial CT scan and a GCS 15 after CT scan completion and, 2) patients with no lesion on the initial cerebral CT scan with at least one of the following risk factors: GCS 14 after CT scan completion, persisting post-traumatic nausea/vomiting/headaches, concomitant alcoholic intoxication or patients treated with aspirin. The study will not include mild TBI patients who are not eligible for early discharge: patients with no possibility of home supervision, those with a GCS lower than 14 after the CT scan or those treated with anticoagulant/antiplatelet drugs other than aspirin. The investigators expect the TCD-based strategy to be non-inferior compared to the standard strategy according to French recommendations in terms of the 3-months neurological outcome. From a public health standpoint, the use of TCD as a triage tool may change current guidelines regarding mild TBI management.
Status | Recruiting |
Enrollment | 984 |
Est. completion date | July 2026 |
Est. primary completion date | May 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: - Mild TBI (GCS 13-15 on ED admission) with one of the following: - Patient with minor cerebral lesion on initial CT scan (TCDBII i.e. no midline shift, visible basal cisterns and haemorrhagic lesion < 25 cc) and GCS 15 after CT scan - OR * Patient with normal initial CT scan (TCDB I) with at least one risk factor : - GCS = 14 after CT scan - and/or alcoholic intoxication - and/or on-going treatment with aspirin - and /or persisting nausea, and/or vomiting and/or headaches - Early initial CT scan (< 4 hours after TBI) - Possibility of home supervision by a third-party - Affiliation to the French social security system - Patient have signed consent form - Possibility to perform a TCD within 8 hours - Stable hemodynamics: systolic blood pressure >90 mmHg, peripheral capillary oxygen saturation >92%, hemoglobin > 8 g/dl Exclusion Criteria: - CT scan classified as TCDB III - VI - Penetrating head-trauma - Patient under mechanical ventilation - Patients treated with anticoagulants or anti-platelet therapy (except Aspirin) - Hospitalization required by post-traumatic extra-cranial lesion, intoxication (except alcoholic), pre-existing condition (including congenital hemostasis disorders) or social factors at the discretion of the physician. - Internal Carotid dissection - Post-traumatic lesion in the posterior cerebral fossa - Subject in exclusion period of another interventional study, - Pregnant women, breastfeeding women - Subject under administrative or judicial control, under protection |
Country | Name | City | State |
---|---|---|---|
France | CH Bourg-en-bresse | Bourg-en-Bresse | |
France | CHU Clermont-Ferrand | Clermont-Ferrand | |
France | CHU Grenoble Alpes | Grenoble | |
France | CHRU Lille | Lille | |
France | HCL - Edouard Herriot | Lyon | |
France | HCL - Lyon Sud | Lyon | |
France | AP-HM Timone | Marseille | |
France | CH Melun | Melun | |
France | CHRU Montpellier | Montpellier | |
France | CHU Nantes | Nantes | |
France | CHU Nîmes | Nîmes | |
France | AP-HP - Avicenne | Paris | |
France | AP-HP Lariboisière | Paris | |
France | AP-HP Pitié Salpetrière | Paris | |
France | CHU Poitiers | Poitiers | |
France | Chu Reunion | Saint Pierre | |
France | CHU Réunion | Saint-Denis | |
France | CHU Toulouse | Toulouse | |
Monaco | CH Monaco | Monaco |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Grenoble |
France, Monaco,
af Geijerstam JL, Britton M. Mild head injury: reliability of early computed tomographic findings in triage for admission. Emerg Med J. 2005 Feb;22(2):103-7. doi: 10.1136/emj.2004.015396. — View Citation
Davis DP, Kene M, Vilke GM, Sise MJ, Kennedy F, Eastman AB, Velky T, Hoyt DB. Head-injured patients who "talk and die": the San Diego perspective. J Trauma. 2007 Feb;62(2):277-81. doi: 10.1097/TA.0b013e31802ef4a3. — View Citation
Maas AIR, Menon DK, Adelson PD, Andelic N, Bell MJ, Belli A, Bragge P, Brazinova A, Buki A, Chesnut RM, Citerio G, Coburn M, Cooper DJ, Crowder AT, Czeiter E, Czosnyka M, Diaz-Arrastia R, Dreier JP, Duhaime AC, Ercole A, van Essen TA, Feigin VL, Gao G, Giacino J, Gonzalez-Lara LE, Gruen RL, Gupta D, Hartings JA, Hill S, Jiang JY, Ketharanathan N, Kompanje EJO, Lanyon L, Laureys S, Lecky F, Levin H, Lingsma HF, Maegele M, Majdan M, Manley G, Marsteller J, Mascia L, McFadyen C, Mondello S, Newcombe V, Palotie A, Parizel PM, Peul W, Piercy J, Polinder S, Puybasset L, Rasmussen TE, Rossaint R, Smielewski P, Soderberg J, Stanworth SJ, Stein MB, von Steinbuchel N, Stewart W, Steyerberg EW, Stocchetti N, Synnot A, Te Ao B, Tenovuo O, Theadom A, Tibboel D, Videtta W, Wang KKW, Williams WH, Wilson L, Yaffe K; InTBIR Participants and Investigators. Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol. 2017 Dec;16(12):987-1048. doi: 10.1016/S1474-4422(17)30371-X. Epub 2017 Nov 6. No abstract available. — View Citation
Tagliaferri F, Compagnone C, Korsic M, Servadei F, Kraus J. A systematic review of brain injury epidemiology in Europe. Acta Neurochir (Wien). 2006 Mar;148(3):255-68; discussion 268. doi: 10.1007/s00701-005-0651-y. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Non-inferiority of a TCD-based strategy after a mild TBI to the standard management in terms of the overall neurological outcome | GOS-E will be dichotomized as good recovery (GOS-E 7 or 8) vs. disability (GOS-E 1 to 6). Evaluation is centralized and blinded. | 3 months after TBI | |
Secondary | Effects of a TCD-based strategy after a mild TBI on the overall neurological outcome | GOS-E will be dichotomized as good recovery (GOS-E 7 or 8) vs. disability (GOS-E 1 to 6). Evaluation is centralized and blinded. | 1 month after TBI | |
Secondary | Effects of a TCD-based strategy after a mild TBI on the quality of life | Questionnaires QOLIBRI (Quality of life after TBI) and EQ-5D-5L | 1 months after TBI | |
Secondary | Effects of a TCD-based strategy after a mild TBI on the quality of life | Questionnaires QOLIBRI (Quality of life after TBI) and EQ-5D-5L | 3 months after TBI | |
Secondary | Effects of a TCD-based strategy after a mild TBI on Post-concussive syndrome | Rivermead Post-Concussion Symptoms questionnaire at 1 month and 3 months after TBI ("Rivermead positive" patients are patients with at least 3 symptoms rated = 2) | 1 month after TBI | |
Secondary | Effects of a TCD-based strategy after a mild TBI on Post-concussive syndrome | Rivermead Post-Concussion Symptoms questionnaire at 1 month and 3 months after TBI ("Rivermead positive" patients are patients with at least 3 symptoms rated = 2) | 3 months after TBI | |
Secondary | Effects of a TCD-based strategy after a mild TBI on Morbidity after TBI | Number of cerebral CT scans within the hospital stay, • Thromboembolic events or diagnosed nosocomial infections stay | 1 months after TBI | |
Secondary | Effects of a TCD-based strategy after a mild TBI on mortality after TBI | Mortality within the first 3 months | 3 months after TBI | |
Secondary | Effects of a TCD-based strategy after a mild TBI on patient safety | Number of patients with neurologic worsening within the first week after TBI. | 3 months after TBI |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04372797 -
Standardized Instruments to Provide Diagnostic and Prognostic Information in Mild Traumatic Brain Injury (mTBI)
|
N/A | |
Completed |
NCT01903525 -
DHA For The Treatment of Pediatric Concussion Related to Sports Injury
|
Phase 1 | |
Completed |
NCT01847040 -
Deployment Related Mild Traumatic Brain Injury (mTBI)
|
||
Completed |
NCT03678077 -
Trends in Cohabitation Status, Academic Achievement and Socio-economic Indicators After Mild Traumatic Brain Injury
|
||
Recruiting |
NCT05682677 -
Combined Neuromodulation and Cognitive Training for Post-mTBI Depression
|
N/A | |
Terminated |
NCT03345550 -
OPTIMA-TBI Pilot Study
|
Phase 2 | |
Completed |
NCT05095012 -
RECOVER Clinical Pathway for Pediatric Concussion
|
N/A | |
Recruiting |
NCT05886400 -
The Effects of Environmental Distractions on SCAT6 Outcomes
|
N/A | |
Recruiting |
NCT05262361 -
Persistent Post-Concussion Symptoms With Convergence Insufficiency
|
N/A | |
Active, not recruiting |
NCT03892291 -
Objective Dual-task Turning Measures for Return-to-duty Assessments
|
||
Completed |
NCT03688984 -
Treatment of Insomnia for Adolescents With Mild Traumatic Brain Injury
|
N/A | |
Completed |
NCT02057081 -
Multifamily Group to Reduce Marital Conflict and Disability in Veterans With mTBI
|
N/A | |
Recruiting |
NCT06233851 -
t-BIOMAP : Prospective Paediatric Cohort Study of Blood Biomarkers in mTBI
|
||
Completed |
NCT02844946 -
One-Day Life Skills Workshop for Veterans With TBI, Pain and Psychopathology
|
N/A | |
Completed |
NCT04641767 -
BIOmarkers of TRAumatic Brain Injury Spain (BIOTRABIS)
|
||
Recruiting |
NCT06112093 -
Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches
|
N/A | |
Recruiting |
NCT03819608 -
Neuromodulation and Neurorehabilitation for mTBI Plus PTSD
|
N/A | |
Withdrawn |
NCT00580918 -
Functional MRI Study of Attention in Normal Controls and Traumatic Brain Injured Patients
|
||
Completed |
NCT03319966 -
Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury
|
||
Recruiting |
NCT03846830 -
Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation
|
N/A |